We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

First Global Guidance for Preventing Cervical Cancer

News   Mar 21, 2017 | Original story from American Society of Clinical Oncology

 
First Global Guidance for Preventing Cervical Cancer

Credit: Pan American Health Organization PAHO flickr feed

 
 
Advertisement
 

RELATED ARTICLES

New Type of Immunotherapy Developed To Fight Cancer

News

A new study reports on a new kind of immunotherapy that gives hope of more treatment options for cancer in the future.

READ MORE

Therapeutic Cancer Vaccine Demonstrates Good Safety and Efficacy in Preclinical Study

News

A checkpoint inhibitor vaccine known as PD1-Vaxx was shown to be safe and effective in a colon cancer syngeneic animal model.

READ MORE

Oxford's COVID-19 Vaccine Has 70% Efficacy Rate

News

There are now over 170 teams of researchers working to develop a vaccine for protection against COVID-19. Over the last few weeks, a number of groups shared interim analysis data on candidates that have reached Phase III clinical testing. The latest addition is the University of Oxford – in collaboration with the pharmaceutical company AstraZeneca – who today announce an efficacy of 70.4% for the candidate, ChAdOx1 nCoV-2019.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE